Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

Milena GianfrancescoKimme L HyrichSarah Al-AdelyLoreto CarmonaMaria I DanilaLaure GossecZara IzadiLindsay JacobsohnPatricia KatzSaskia Lawson-ToveyElsa F MateusStephanie RushGabriela SchmajukJulia SimardAnja StrangfeldLaura TrupinKatherine D WyshamSuleman BhanaWendy CostelloRebecca GraingerJonathan S HausmannJean W LiewEmily SirotichPaul SufkaZachary S WallaceJinoos YazdanyPedro M Machado Philip C Robinsonnull null

Published in: Annals of the rheumatic diseases (2020)

We found that glucocorticoid exposure of ≥10 mg/day is associated with a higher odds of hospitalisation and anti-TNF with a decreased odds of hospitalisation in patients with rheumatic disease. Neither exposure to DMARDs nor NSAIDs were associated with increased odds of hospitalisation.

Keyphrases

coronavirus disease
rheumatoid arthritis
sars cov
emergency department
primary care
electronic health record
big data
data analysis